Benzo-fused heterocyclic derivatives useful as agonists of GPR120
US-9562053-B2 · Feb 7, 2017 · US
US10730847B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10730847-B2 |
| Application number | US-201816195553-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 19, 2018 |
| Priority date | Mar 14, 2013 |
| Publication date | Aug 4, 2020 |
| Grant date | Aug 4, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is directed to benzo-fused heterocyclic derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by GPR120. More particularly, the compounds of the present invention are agonists of GPR120, useful in the treatment of, such as for example, Type II diabetes mellitus.
Opening claim text (preview).
We claim: 1. A process for making a pharmaceutical composition comprising mixing a compound selected from the group consisting of: 3-{4-[(5-Chloro-2-ethyl-1-benzofuran-7-yl)methoxy]-2,3-dimethylphenyl}propanoic acid; 3-(2,3-Dimethyl-4-{[2-methyl-5-(trifluoromethoxy)-1-benzofuran-7-yl]methoxy}phenyl)propanoic acid; 3-(7-{[2-Methyl-5-(trifluoromethoxy)-1-benzofuran-7-yl]methoxy}-2,3-dihydro-1H-inden-4-yl)propanoic acid; 3-{4-[(5-Chloro-2-methyl-1-benzofuran-7-yl)methoxy]-2,3-dimethylphenyl}propanoic acid; 3-{4-[(5-Chloro-2,6-dimethyl-1-benzofuran-7-yl)methoxy]-2,3-dimethylphenyl}propanoic acid; 3-(4-{[2-(2-Fluoroethenyl)-5-(trifluoromethoxy)-1-benzofuran-7-yl]methoxy}-2,3-dimethylphenyl)propanoic acid; 3-{4-[(6-Chloro-2-methyl-1,3-benzothiazol-4-yl)methoxy]-2,3-dimethylphenyl}propanoic acid; and pharmaceutically acceptable salts thereof; with a pharmaceutically acceptable carrier.
Ortho-condensed systems · CPC title
Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen · CPC title
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring · CPC title
Radicals substituted by nitrogen atoms not forming part of a nitro radical · CPC title
Radicals substituted by oxygen atoms · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.